The U.S. Food and Drug Administration has reversed an earlier decision and said it will review drugmaker Moderna's application for approval of a seasonal flu vaccine, the company said in a statement W...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA 4.03% application to sell a new seasonal flu shot after the vaccine maker agreed to conduct additional t...